Intraoperative Neuromonitoring Market By Products and Services, By Source Type, By Application, By Modality, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

According to a new report published by Allied Market Research, titled, "Intraoperative Neuromonitoring Market," The intraoperative neuromonitoring market was valued at $4.8 billion in 2022, and is estimated to reach $8.7 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032. Intraoperative neuromonitoring (IONM) is a medical technique employed during surgery to assess and safeguard the integrity of the nervous system. Through real-time monitoring of neural structures, including the brain, spinal cord, and peripheral nerves, IONM aims to prevent potential damage and guide surgeons in making informed decisions. Electrodes are strategically placed to record and analyze electrical signals, allowing for the identification of any anomalies or potential risks. By continuously evaluating the nervous system's function throughout the surgical procedure, IONM enhances patient safety and contributes to better surgical outcomes by enabling prompt adjustments to minimize the risk of neurological complications.

Intraoperative Neuromonitoring Market - IMG1

The major factor driving the growth of the intraoperative neuromonitoring market is prevalence of chronic diseases, encompassing neurological disorders, cardiovascular conditions, and osteoarthritis. These conditions often require surgical intervention, where intraoperative neuromonitoring emerges as a pivotal tool, enhancing surgical precision and minimizing complications. In addition, the rise in number of surgical procedures further drives the market growth. For instance, in 2022, a White Paper from Etiometry Inc., a digital health company, reported that approximately 900,000 cardiac surgeries are performed annually in the U.S., with an average increase in surgery volume of 5% per year. Further, with an aging population, the prevalence of chronic diseases is expected to soar, leading to a higher frequency of complex surgeries. This demographic shift is anticipated to be a key driver, fostering sustained market growth for intraoperative neuromonitoring as an indispensable component of advanced surgical practices.

Moreover, the presence of favorable reimbursement policies significantly contributes to the robust growth of the intraoperative neuromonitoring market. As healthcare systems acknowledge the importance of these monitoring technologies in ensuring patient safety during surgeries, supportive reimbursement frameworks incentivize healthcare providers to integrate intraoperative neuromonitoring into their practices. Reimbursement policies not only alleviate financial burdens on healthcare facilities but also encourage broader adoption, making these advanced monitoring solutions more accessible. This alignment between the benefits of intraoperative neuromonitoring and favorable reimbursement policies serves as a key catalyst, fostering a conducive environment for sustained market expansion.

The intraoperative neuromonitoring market is segmented on the basis of products & services, source type, application, modality, end user, and region. On the basis of product & service, the market is segmented into system, accessory, and service. As per source type, the market is segmented into insourced monitoring and outsourced monitoring. Depending on application, the market is segmented into spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries. On the basis of modality, the market is segmented into motor evoked potential (MEPs), somatosensory evoked potential (SSEPs), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potential (BAEPs), and visual evoked potential (VEPs). According to end user, market is segmented into hospitals and ambulatory surgical centers (ASCs). Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The major key players that operate in the global intraoperative neuromonitoring market are NuVasive, Inc.,Medtronic plc, Natus Medical Incorporated, inomed Medizintechnik GmbH, Nihon Kohden Corporation, Accurate Monitoring, Computational Diagnostics, Inc., SpecialtyCare, NeuroStyle Pte. Ltd, and Intranerve Neuroscience Holdings, LLC.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intraoperative neuromonitoring market analysis from 2022 to 2032 to identify the prevailing intraoperative neuromonitoring market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the intraoperative neuromonitoring market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global intraoperative neuromonitoring market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Products and Services

Systems
Accessories
Services

By Source Type

Insourced Monitoring
Outsourced Monitoring

By Application

Spinal Surgery
Neurosurgery
Orthopedic Surgery
ENT Surgery
Vascular Surgery
Other surgeries

By Modality

Motor evoked potentials (MEPs)
Somatosensory evoked potentials (SSEPs)
Electroencephalography (EEG)
Electromyography (EMG)
Brainstem auditory evoked potentials (BAEPs)
Visual evoked potentials (VEPs)

By End User

Hospitals
Ambulatory Surgical Centers (ASCs)

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Medtronic plc
inomed Medizintechnik GmbH
Nihon Kohden Corporation
Accurate Monitoring
SpecialtyCare
NeuroStyle Pte.Ltd
Intranerve Neuroscience Holdings, LLC
Natus Medical Incorporated.
Computational Diagnostics, Inc.
NuVasive, Inc.

Product Code: A01590

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Rise in prevalence of chronic diseases
  - 3.4.1.2. Rise in geriatric population
  - 3.4.1.3. Applications of IONM in various surgeries
- 3.4.2. Restraints
  - 3.4.2.1. Dearth of skilled professionals
- 3.4.3. Opportunities
  - 3.4.3.1. Growth opportunities in emerging markets

CHAPTER 4: INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Systems
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Accessories
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Services
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country

CHAPTER 5: INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Insourced Monitoring
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Outsourced Monitoring
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country

CHAPTER 6: INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Spinal Surgery
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Neurosurgery
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Orthopedic Surgery
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
6.5. ENT Surgery
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by region
- 6.5.3. Market share analysis by country
6.6. Vascular Surgery
- 6.6.1. Key market trends, growth factors and opportunities
- 6.6.2. Market size and forecast, by region
- 6.6.3. Market share analysis by country
6.7. Other surgeries
- 6.7.1. Key market trends, growth factors and opportunities
- 6.7.2. Market size and forecast, by region
- 6.7.3. Market share analysis by country

CHAPTER 7: INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY

7.1. Overview
- 7.1.1. Market size and forecast
7.2. Motor evoked potentials (MEPs)
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
7.3. Somatosensory evoked potentials (SSEPs)
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
7.4. Electroencephalography (EEG)
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country
7.5. Electromyography (EMG)
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by region
- 7.5.3. Market share analysis by country
7.6. Brainstem auditory evoked potentials (BAEPs)
- 7.6.1. Key market trends, growth factors and opportunities
- 7.6.2. Market size and forecast, by region
- 7.6.3. Market share analysis by country
7.7. Visual evoked potentials (VEPs)
- 7.7.1. Key market trends, growth factors and opportunities
- 7.7.2. Market size and forecast, by region
- 7.7.3. Market share analysis by country

CHAPTER 8: INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER

8.1. Overview
- 8.1.1. Market size and forecast
8.2. Hospitals
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by region
- 8.2.3. Market share analysis by country
8.3. Ambulatory Surgical Centers (ASCs)
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by region
- 8.3.3. Market share analysis by country

CHAPTER 9: INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION

9.1. Overview
- 9.1.1. Market size and forecast By Region
9.2. North America
- 9.2.1. Key market trends, growth factors and opportunities
- 9.2.2. Market size and forecast, by Products and Services
- 9.2.3. Market size and forecast, by Source Type
- 9.2.4. Market size and forecast, by Application
- 9.2.5. Market size and forecast, by Modality
- 9.2.6. Market size and forecast, by End User
- 9.2.7. Market size and forecast, by country
  - 9.2.7.1. U.S.
  - 9.2.7.1.1. Market size and forecast, by Products and Services
  - 9.2.7.1.2. Market size and forecast, by Source Type
  - 9.2.7.1.3. Market size and forecast, by Application
  - 9.2.7.1.4. Market size and forecast, by Modality
  - 9.2.7.1.5. Market size and forecast, by End User
  - 9.2.7.2. Canada
  - 9.2.7.2.1. Market size and forecast, by Products and Services
  - 9.2.7.2.2. Market size and forecast, by Source Type
  - 9.2.7.2.3. Market size and forecast, by Application
  - 9.2.7.2.4. Market size and forecast, by Modality
  - 9.2.7.2.5. Market size and forecast, by End User
  - 9.2.7.3. Mexico
  - 9.2.7.3.1. Market size and forecast, by Products and Services
  - 9.2.7.3.2. Market size and forecast, by Source Type
  - 9.2.7.3.3. Market size and forecast, by Application
  - 9.2.7.3.4. Market size and forecast, by Modality
  - 9.2.7.3.5. Market size and forecast, by End User
9.3. Europe
- 9.3.1. Key market trends, growth factors and opportunities
- 9.3.2. Market size and forecast, by Products and Services
- 9.3.3. Market size and forecast, by Source Type
- 9.3.4. Market size and forecast, by Application
- 9.3.5. Market size and forecast, by Modality
- 9.3.6. Market size and forecast, by End User
- 9.3.7. Market size and forecast, by country
  - 9.3.7.1. Germany
  - 9.3.7.1.1. Market size and forecast, by Products and Services
  - 9.3.7.1.2. Market size and forecast, by Source Type
  - 9.3.7.1.3. Market size and forecast, by Application
  - 9.3.7.1.4. Market size and forecast, by Modality
  - 9.3.7.1.5. Market size and forecast, by End User
  - 9.3.7.2. France
  - 9.3.7.2.1. Market size and forecast, by Products and Services
  - 9.3.7.2.2. Market size and forecast, by Source Type
  - 9.3.7.2.3. Market size and forecast, by Application
  - 9.3.7.2.4. Market size and forecast, by Modality
  - 9.3.7.2.5. Market size and forecast, by End User
  - 9.3.7.3. UK
  - 9.3.7.3.1. Market size and forecast, by Products and Services
  - 9.3.7.3.2. Market size and forecast, by Source Type
  - 9.3.7.3.3. Market size and forecast, by Application
  - 9.3.7.3.4. Market size and forecast, by Modality
  - 9.3.7.3.5. Market size and forecast, by End User
  - 9.3.7.4. Italy
  - 9.3.7.4.1. Market size and forecast, by Products and Services
  - 9.3.7.4.2. Market size and forecast, by Source Type
  - 9.3.7.4.3. Market size and forecast, by Application
  - 9.3.7.4.4. Market size and forecast, by Modality
  - 9.3.7.4.5. Market size and forecast, by End User
  - 9.3.7.5. Spain
  - 9.3.7.5.1. Market size and forecast, by Products and Services
  - 9.3.7.5.2. Market size and forecast, by Source Type
  - 9.3.7.5.3. Market size and forecast, by Application
  - 9.3.7.5.4. Market size and forecast, by Modality
  - 9.3.7.5.5. Market size and forecast, by End User
  - 9.3.7.6. Rest of Europe
  - 9.3.7.6.1. Market size and forecast, by Products and Services
  - 9.3.7.6.2. Market size and forecast, by Source Type
  - 9.3.7.6.3. Market size and forecast, by Application
  - 9.3.7.6.4. Market size and forecast, by Modality
  - 9.3.7.6.5. Market size and forecast, by End User
9.4. Asia-Pacific
- 9.4.1. Key market trends, growth factors and opportunities
- 9.4.2. Market size and forecast, by Products and Services
- 9.4.3. Market size and forecast, by Source Type
- 9.4.4. Market size and forecast, by Application
- 9.4.5. Market size and forecast, by Modality
- 9.4.6. Market size and forecast, by End User
- 9.4.7. Market size and forecast, by country
  - 9.4.7.1. Japan
  - 9.4.7.1.1. Market size and forecast, by Products and Services
  - 9.4.7.1.2. Market size and forecast, by Source Type
  - 9.4.7.1.3. Market size and forecast, by Application
  - 9.4.7.1.4. Market size and forecast, by Modality
  - 9.4.7.1.5. Market size and forecast, by End User
  - 9.4.7.2. China
  - 9.4.7.2.1. Market size and forecast, by Products and Services
  - 9.4.7.2.2. Market size and forecast, by Source Type
  - 9.4.7.2.3. Market size and forecast, by Application
  - 9.4.7.2.4. Market size and forecast, by Modality
  - 9.4.7.2.5. Market size and forecast, by End User
  - 9.4.7.3. India
  - 9.4.7.3.1. Market size and forecast, by Products and Services
  - 9.4.7.3.2. Market size and forecast, by Source Type
  - 9.4.7.3.3. Market size and forecast, by Application
  - 9.4.7.3.4. Market size and forecast, by Modality
  - 9.4.7.3.5. Market size and forecast, by End User
  - 9.4.7.4. Australia
  - 9.4.7.4.1. Market size and forecast, by Products and Services
  - 9.4.7.4.2. Market size and forecast, by Source Type
  - 9.4.7.4.3. Market size and forecast, by Application
  - 9.4.7.4.4. Market size and forecast, by Modality
  - 9.4.7.4.5. Market size and forecast, by End User
  - 9.4.7.5. South Korea
  - 9.4.7.5.1. Market size and forecast, by Products and Services
  - 9.4.7.5.2. Market size and forecast, by Source Type
  - 9.4.7.5.3. Market size and forecast, by Application
  - 9.4.7.5.4. Market size and forecast, by Modality
  - 9.4.7.5.5. Market size and forecast, by End User
  - 9.4.7.6. Rest of Asia-Pacific
  - 9.4.7.6.1. Market size and forecast, by Products and Services
  - 9.4.7.6.2. Market size and forecast, by Source Type
  - 9.4.7.6.3. Market size and forecast, by Application
  - 9.4.7.6.4. Market size and forecast, by Modality
  - 9.4.7.6.5. Market size and forecast, by End User
9.5. LAMEA
- 9.5.1. Key market trends, growth factors and opportunities
- 9.5.2. Market size and forecast, by Products and Services
- 9.5.3. Market size and forecast, by Source Type
- 9.5.4. Market size and forecast, by Application
- 9.5.5. Market size and forecast, by Modality
- 9.5.6. Market size and forecast, by End User
- 9.5.7. Market size and forecast, by country
  - 9.5.7.1. Brazil
  - 9.5.7.1.1. Market size and forecast, by Products and Services
  - 9.5.7.1.2. Market size and forecast, by Source Type
  - 9.5.7.1.3. Market size and forecast, by Application
  - 9.5.7.1.4. Market size and forecast, by Modality
  - 9.5.7.1.5. Market size and forecast, by End User
  - 9.5.7.2. Saudi Arabia
  - 9.5.7.2.1. Market size and forecast, by Products and Services
  - 9.5.7.2.2. Market size and forecast, by Source Type
  - 9.5.7.2.3. Market size and forecast, by Application
  - 9.5.7.2.4. Market size and forecast, by Modality
  - 9.5.7.2.5. Market size and forecast, by End User
  - 9.5.7.3. South Africa
  - 9.5.7.3.1. Market size and forecast, by Products and Services
  - 9.5.7.3.2. Market size and forecast, by Source Type
  - 9.5.7.3.3. Market size and forecast, by Application
  - 9.5.7.3.4. Market size and forecast, by Modality
  - 9.5.7.3.5. Market size and forecast, by End User
  - 9.5.7.4. Rest of LAMEA
  - 9.5.7.4.1. Market size and forecast, by Products and Services
  - 9.5.7.4.2. Market size and forecast, by Source Type
  - 9.5.7.4.3. Market size and forecast, by Application
  - 9.5.7.4.4. Market size and forecast, by Modality
  - 9.5.7.4.5. Market size and forecast, by End User

CHAPTER 10: COMPETITIVE LANDSCAPE

10.1. Introduction
10.2. Top winning strategies
10.3. Product mapping of top 10 player
10.4. Competitive dashboard
10.5. Competitive heatmap
10.6. Top player positioning, 2022

CHAPTER 11: COMPANY PROFILES

11.1. NuVasive, Inc.
- 11.1.1. Company overview
- 11.1.2. Key executives
- 11.1.3. Company snapshot
- 11.1.4. Operating business segments
- 11.1.5. Product portfolio
- 11.1.6. Business performance
11.2. Medtronic plc
- 11.2.1. Company overview
- 11.2.2. Key executives
- 11.2.3. Company snapshot
- 11.2.4. Operating business segments
- 11.2.5. Product portfolio
- 11.2.6. Business performance
- 11.2.7. Key strategic moves and developments
11.3. Computational Diagnostics, Inc.
- 11.3.1. Company overview
- 11.3.2. Key executives
- 11.3.3. Company snapshot
- 11.3.4. Operating business segments
- 11.3.5. Product portfolio
11.4. Natus Medical Incorporated.
- 11.4.1. Company overview
- 11.4.2. Key executives
- 11.4.3. Company snapshot
- 11.4.4. Operating business segments
- 11.4.5. Product portfolio
- 11.4.6. Business performance
11.5. Accurate Monitoring
- 11.5.1. Company overview
- 11.5.2. Key executives
- 11.5.3. Company snapshot
- 11.5.4. Operating business segments
- 11.5.5. Product portfolio
11.6. inomed Medizintechnik GmbH
- 11.6.1. Company overview
- 11.6.2. Key executives
- 11.6.3. Company snapshot
- 11.6.4. Operating business segments
- 11.6.5. Product portfolio
11.7. Nihon Kohden Corporation
- 11.7.1. Company overview
- 11.7.2. Key executives
- 11.7.3. Company snapshot
- 11.7.4. Operating business segments
- 11.7.5. Product portfolio
- 11.7.6. Business performance
11.8. SpecialtyCare
- 11.8.1. Company overview
- 11.8.2. Key executives
- 11.8.3. Company snapshot
- 11.8.4. Operating business segments
- 11.8.5. Product portfolio
11.9. Intranerve Neuroscience Holdings, LLC
- 11.9.1. Company overview
- 11.9.2. Key executives
- 11.9.3. Company snapshot
- 11.9.4. Operating business segments
- 11.9.5. Product portfolio
- 11.9.6. Key strategic moves and developments
11.10. NeuroStyle Pte.Ltd
- 11.10.1. Company overview
- 11.10.2. Key executives
- 11.10.3. Company snapshot
- 11.10.4. Operating business segments
- 11.10.5. Product portfolio